Teva's Actavis again loses bid to invalidate Quillivant ADHD drug patents | Reuters
Actavis deal is not the root of all evil for Teva
KASTRUP /DENMARK- Cholestrol pills Atorvatin Teva 10 mg and Atorovastatin Actavis 10 mg in different prices for sale 30 August 2014 (Photo by Francis Dean/Deanpictures Stock Photo - Alamy
Actavis Farmacêutica Ltda (Teva Group) | LinkedIn
Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher | The Motley Fool
Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Intas buys Actavis assets in UK, Ireland for Rs 5,100cr - Times of India
Teva to buy German generic drug maker Ratiopharm - The San Diego Union-Tribune
States reach deal over marketing, safety of generic opioids - WBBJ TV
Teva unclear on which generics affected by Actavis buyout :: C+D
Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail - TheStreet
Teva closes on $4.25bn deal to settle US-wide opioid litigation | pharmaphorum
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Completes Acquisition of Actavis Generics | Business Wire
Intas Pharma to buy Teva's UK, Ireland generics businesses | Mint
Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough | Fox Business
Teva and Actavis sued over acne drug
Actavis bought by Israeli pharmaceutical company - MaltaProfile.info
Teva buys Allergan's generic drug unit for $40.5B
Actavis - Wikipedia
Teva completes $40 billion acquisition of Actavis Generics | Pharmafile
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
